Must Read Rumors

Duchess Kate isn’t pregnant with baby no.3, despite report

A new rumor has surfaced, claiming that the royal couple is expecting their third child.

Meghan Markle avoids Prince Harry questions at ATX panel

Meghan Markle was faced with the question that everyone is curious about.

Kate Middleton and Prince William to embark on royal tour of Poland and Germany

The Duke and Duchess of Cambridge, née Kate Middleton, have announced an official visit to the two countries in July.

Kate Middleton reveals her and Pippa’s nicknames in school

The Duchess of Cambridge, née Kate Middleton, visited her former school in Berkshire. For the occasion, she unveiled the nicknames she and her sister Pippa had when they were children.

Duchess Kate shines in marine outfit at London event

The Duchess of Cambridge, née Kate Middleton, sported a simple but elegant look when she visited the Docklands Sailing and Watersports Centre in London this week.

Duchess Kate isn’t pregnant with baby no.3, despite report
Meghan Markle avoids Prince Harry questions at ATX panel
Kate Middleton and Prince William to embark on royal tour of Poland and Germany
Kate Middleton reveals her and Pippa’s nicknames in school
Duchess Kate shines in marine outfit at London event

The Bluetooth pill to appear in European hospitals soon

by Nicole
November 12, 2010 at 3:22 pm

Miniaturization has always been a safe way to remarkable advances in microprocessor industry, allowing not only the manufacturing of microchips, but also a greater degree of integration for equipment with a high degree of complexity.

One of the areas that most benefit this is medicine, a domain in which miniaturization has enabled the creation of more sophisticated prostheses, and intelligent diagnostic equipment, small enough to fit inside a capsule.

One of the first companies to bring such devices in mass production is Novartis AG Sweden, with its “Ingestible Event Marker.” Small enough to be incorporated into the pill capsules, this microchip, activated after ingestion by contact with the stomach acids, may send biometric information to assess the effectiveness of the administered drug.

Parameters such as body temperature, heart rate and movements of the patient can be monitored, as information is transmitted in real time via Bluetooth.

Initially, this technology will be used only for monitoring high-risk patients such as those undergoing transplant operations, but could be extended to other areas.

If tests show that adding such microchips does not change the curative properties of pills, the product could be approved for general use in European countries over the next 18 months.

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions